SLAM

Sanlam Allianz trades at 9.88 KES. The value pillar ranks strongest, scoring 93—anchored by a P/E of 7.9, a price-to-book ratio of 0.35, and earnings yield of 12.7% that exceeds the 364-day T-bill rate of 9.03% by 3.6 percentage points; revenue and earnings grew 43.8% year-over-year. The health pillar achieves a perfect score, with all nine F-Score signals passed. Quality and liquidity rank far weaker: profitability remains thin, with return on equity of 4.4% and net margin of 3.9%, though the margin has expanded 1.4 percentage points over the observation window; trading volume is sparse, with median daily turnover near 153,180 KES. Dividend pillar scores zero—no dividend was paid in either of the two observed fiscal years.

An overall verdict is withheld. The newest financial statement is 22 months old, and only two years of history exist when three are needed for robust pattern detection; momentum data has been building since July 2026 and remains incomplete. The earnings yield advantage over the T-bill and the F-Score perfection suggest operational soundness, yet thin profitability metrics and the complete absence of dividends present material constraints. Price and EPS are current as of 3 November 2026. Data confidence is rated C. A fresh annual filing or a third year of results would clarify whether recent growth and margin expansion are sustainable.

Automated analysis for information & education. Not investment advice.